Key facts
- Huxley Medical’s last known valuation is $82.0M (Feb 2026).
- It has raised $32.7M across 8 recorded rounds; the latest was Seed Round ($3.0M) in Apr 2026.
- Notable investors include US National Science Foundation, National Institutes of Health, Duke Capital Partners, Advanced Technology Development Center, GRA Venture Fund — 6 tracked in total.
- Huxley Medical has filed 9 Form Ds with the SEC since 2023, most recently Jun 2026 ($3.0M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 8 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Huxley Medical
Funding rounds
8 roundsAbout Huxley Medical
Developer of a flexible medical platform designed to provide patients with continuity of care regardless of location or healthcare. The company's platform collaborates with thought-leading clinicians and basic science researchers to develop and market devices and algorithms, enabling users to get increased access to multiple disease diagnoses and treatments.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2019
- Employees
- 43
- Website
- huxleymed.com/
- Ownership
- Privately Held (backing)
Huxley Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huxley Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huxley Medical in its N-PORT filings yet. We sweep new filings monthly.